MediWound MDWD
NASDAQ MDWD
$13.73 -0.11 (-0.79%)
As of: Sep 10, 2026 · 3:59 PM EDT

MediWound (MDWD) Total Current Liabilities (2013 - 2026)

MediWound (MDWD) posted Total Current Liabilities of $18.5 million for Q2 2026, down 14.34% on a QoQ basis from $21.6 million in Q1 2026, and down 36.21% year-over-year from $29.1 million in Q2 2025.

Analysis

MediWound (MDWD) Total Current Liabilities (2013 - 2026) Analysis & Trends

MediWound has reported Total Current Liabilities for 13 years, with the latest figure at $18.5 million in Q2 2026.

  • On a quarterly basis, Total Current Liabilities fell 36.21% year-over-year to $18.5 million in Q2 2026; TTM through Jun 2026 was $18.5 million, a 36.21% decrease from a year earlier, with the FY2025 full-year figure at $25.7 million, down 3.14% from the prior year.
  • Total Current Liabilities was $18.5 million for Q2 2026 at MediWound, down from $21.6 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $29.1 million in Q2 2025, with the low at $9.0 million in Q3 2022.
  • Average Total Current Liabilities over 5 years is $20.0 million, with a median of $21.7 million recorded in 2025.
  • The sharpest annual moves came in 2023 and 2026: Total Current Liabilities soared 112.78% in 2023, then plunged 36.21% in 2026.
  • Over 5 years, Total Current Liabilities stood at $12.1 million in 2022, then jumped by 50.33% to $18.1 million in 2023, then soared by 46.43% to $26.5 million in 2024, then declined by 3.14% to $25.7 million in 2025, then declined by 27.87% to $18.5 million in 2026.
  • The last three Total Current Liabilities figures came in at $18.5 million (Q2 2026), $21.6 million (Q1 2026), and $25.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 25.50 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 11.02 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 3.94 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 5.53 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.58 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 2.53 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.51 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 3.92 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 283.60 Mn
10 MediWound 156.09 Mn 120.75 Mn 337,000.00 18.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.54 Mn
Mar 31, 2026 21.65 Mn
Dec 31, 2025 25.71 Mn
Sep 30, 2025 26.25 Mn
Jun 30, 2025 29.07 Mn
Mar 31, 2025 21.84 Mn
Dec 31, 2024 26.54 Mn
Sep 30, 2024 25.58 Mn
Jun 30, 2024 22.61 Mn
Mar 31, 2024 22.34 Mn
Dec 31, 2023 18.13 Mn
Sep 30, 2023 17.34 Mn
Jun 30, 2023 17.99 Mn
Mar 31, 2023 23.94 Mn
Dec 31, 2022 12.06 Mn
Sep 30, 2022 9.01 Mn
Jun 30, 2022 10.42 Mn
Mar 31, 2022 11.25 Mn
Dec 31, 2021 10.72 Mn
Sep 30, 2021 9.96 Mn